These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28035862)

  • 1. Reply: Heparin versus Warfarin in Interstitial Pulmonary Fibrosis: The Quest for the Right Anticoagulant Continues.
    Margaritopoulos GA; Antoniou KM
    Am J Respir Crit Care Med; 2017 Jan; 195(1):142-143. PubMed ID: 28035862
    [No Abstract]   [Full Text] [Related]  

  • 2. Warfarin in idiopathic pulmonary fibrosis: friend or foe, is it a matter of genes and heparin? : a reply to Tzouvelekis.
    Noth I; Olman M;
    Am J Respir Crit Care Med; 2013 Jan; 187(2):214. PubMed ID: 23441317
    [No Abstract]   [Full Text] [Related]  

  • 3. Warfarin in idiopathic pulmonary fibrosis: friend or foe, is it a matter of genes and heparin?
    Tzouvelekis A; Margaritopoulos G; Loukides S; Bouros D
    Am J Respir Crit Care Med; 2013 Jan; 187(2):213-4. PubMed ID: 23322796
    [No Abstract]   [Full Text] [Related]  

  • 4. Is warfarin the right anticoagulant in idiopathic pulmonary fibrosis?
    Bendstrup E; Hilberg O
    Am J Respir Crit Care Med; 2012 Oct; 186(7):693; author reply 693-4. PubMed ID: 23027854
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of anticoagulant therapy for idiopathic pulmonary fibrosis in real life practice.
    Tomassetti S; Ruy JH; Gurioli C; Ravaglia C; Buccioli M; Tantalocco P; Decker PA; Cavazza A; Dubini A; Agnoletti V; Gurioli C; Casoni GL; Romagnoli M; Poletti V
    Sarcoidosis Vasc Diffuse Lung Dis; 2013 Aug; 30(2):121-7. PubMed ID: 24071883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reply: rationale for anticoagulant therapy of pulmonary fibrosis.
    Noth I; Olman MA
    Am J Respir Crit Care Med; 2014 Feb; 189(3):363. PubMed ID: 24484338
    [No Abstract]   [Full Text] [Related]  

  • 7. Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.
    Kreuter M; Wijsenbeek MS; Vasakova M; Spagnolo P; Kolb M; Costabel U; Weycker D; Kirchgaessler KU; Maher TM
    Eur Respir J; 2016 Jun; 47(6):1776-84. PubMed ID: 27103382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reply: A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis: a hidden subgroup?
    Noth I; Olman M;
    Am J Respir Crit Care Med; 2013 May; 187(9):1030. PubMed ID: 23634866
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence-based recommendations in idiopathic pulmonary fibrosis: a year is a long time in interstitial lung disease.
    Müller-Quernheim J; Wells A
    Am J Respir Crit Care Med; 2012 Jul; 186(1):5-7. PubMed ID: 22753682
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulant therapy for idiopathic pulmonary fibrosis.
    Kubo H; Nakayama K; Yanai M; Suzuki T; Yamaya M; Watanabe M; Sasaki H
    Chest; 2005 Sep; 128(3):1475-82. PubMed ID: 16162746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for anticoagulant therapy of pulmonary fibrosis.
    Bogatkevich GS; Nietert PJ; Silver RM; Highland KB
    Am J Respir Crit Care Med; 2014 Feb; 189(3):362-3. PubMed ID: 24484337
    [No Abstract]   [Full Text] [Related]  

  • 12. A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis: a hidden subgroup?
    Kubo H; Yanai M; Azuma A
    Am J Respir Crit Care Med; 2013 May; 187(9):1029-30. PubMed ID: 23634865
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anticoagulant therapy for idiopathic pulmonary fibrosis].
    Kubo H
    Rev Port Pneumol; 2005; 11(6):591-2. PubMed ID: 16521238
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and tolerability of inhaled heparin in idiopathic pulmonary fibrosis.
    Markart P; Nass R; Ruppert C; Hundack L; Wygrecka M; Korfei M; Boedeker RH; Staehler G; Kroll H; Scheuch G; Seeger W; Guenther A
    J Aerosol Med Pulm Drug Deliv; 2010 Jun; 23(3):161-72. PubMed ID: 20109123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of gastrointestinal bleeding with direct oral anticoagulants: a systematic review and network meta-analysis.
    Burr N; Lummis K; Sood R; Kane JS; Corp A; Subramanian V
    Lancet Gastroenterol Hepatol; 2017 Feb; 2(2):85-93. PubMed ID: 28403994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. We should prohibit warfarin in idiopathic pulmonary fibrosis.
    Alagha K; Secq V; Pahus L; Sofalvi T; Palot A; Bourdin A; Chanez P
    Am J Respir Crit Care Med; 2015 Apr; 191(8):958-60. PubMed ID: 25876206
    [No Abstract]   [Full Text] [Related]  

  • 17. Taking Warfarin with Heparin Replacement and Direct Oral Anticoagulant Is a Risk Factor for Bleeding after Endoscopic Submucosal Dissection for Early Gastric Cancer.
    Sanomura Y; Oka S; Tanaka S; Yorita N; Kuroki K; Kurihara M; Mizumoto T; Yoshifuku Y; Chayama K
    Digestion; 2018; 97(3):240-249. PubMed ID: 29421806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antithrombotic and hemorrhagic effects of edoxaban, a novel factor Xa inhibitor, with unfractionated heparin, dalteparin, lepirudin and warfarin in rats.
    Morishima Y; Honda Y; Kamisato C; Shibano T
    Thromb Res; 2013 Aug; 132(2):234-9. PubMed ID: 23768448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulants in older patients. A safety perspective.
    Beyth RJ; Landefeld CS
    Drugs Aging; 1995 Jan; 6(1):45-54. PubMed ID: 7696778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ANTICOAGULANT TREATMENT].
    WELTI JJ
    Cah Coll Med Hop Paris; 1964 Jan; 5():49-55. PubMed ID: 14127371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.